ATE289203T1 - Behandlung von konjunktivitis mit histacalin proteinen - Google Patents

Behandlung von konjunktivitis mit histacalin proteinen

Info

Publication number
ATE289203T1
ATE289203T1 AT00954784T AT00954784T ATE289203T1 AT E289203 T1 ATE289203 T1 AT E289203T1 AT 00954784 T AT00954784 T AT 00954784T AT 00954784 T AT00954784 T AT 00954784T AT E289203 T1 ATE289203 T1 AT E289203T1
Authority
AT
Austria
Prior art keywords
conjunctivitis
treatment
proteins
histacalin
effective
Prior art date
Application number
AT00954784T
Other languages
English (en)
Inventor
Patricia Anne Nuttall
Guido Christiaan Paesen
Original Assignee
Evolutec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolutec Ltd filed Critical Evolutec Ltd
Application granted granted Critical
Publication of ATE289203T1 publication Critical patent/ATE289203T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Surface Treatment Of Glass (AREA)
  • Polarising Elements (AREA)
AT00954784T 1999-09-01 2000-08-24 Behandlung von konjunktivitis mit histacalin proteinen ATE289203T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920674.0A GB9920674D0 (en) 1999-09-01 1999-09-01 Treatment of conjunctivitis
PCT/GB2000/003282 WO2001015719A2 (en) 1999-09-01 2000-08-24 Treatment of conjunctivitis

Publications (1)

Publication Number Publication Date
ATE289203T1 true ATE289203T1 (de) 2005-03-15

Family

ID=10860170

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954784T ATE289203T1 (de) 1999-09-01 2000-08-24 Behandlung von konjunktivitis mit histacalin proteinen

Country Status (17)

Country Link
US (1) US6737399B2 (de)
EP (1) EP1207898B1 (de)
JP (1) JP2003508445A (de)
CN (1) CN1382057A (de)
AT (1) ATE289203T1 (de)
AU (1) AU780773B2 (de)
BR (1) BR0013665A (de)
CA (1) CA2382473A1 (de)
DE (1) DE60018192T2 (de)
DK (1) DK1207898T3 (de)
ES (1) ES2235930T3 (de)
GB (1) GB9920674D0 (de)
HK (1) HK1046362B (de)
MX (1) MXPA02001807A (de)
NZ (1) NZ517218A (de)
PT (1) PT1207898E (de)
WO (1) WO2001015719A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307544D0 (en) * 2003-04-01 2003-05-07 Evolutec Ltd Treatment method
GB0809279D0 (en) * 2008-05-21 2008-06-25 Varleigh Ltd Histamine binding protein
JP6794454B2 (ja) * 2015-09-25 2020-12-02 オコジェン、インコーポレイテッドＯｋｏｇｅｎ， Ｉｎｃ． ランピルナーゼおよび／またはアンフィナーゼを使用するウイルス性結膜炎の処置
GB201720505D0 (en) * 2017-12-08 2018-01-24 Volution Immuno Pharmaceuticals Sa Methods for treatment of neuropathic pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2253924C (en) * 1996-05-18 2012-03-06 Oxford Vacs Ltd. Vasoactive amine binding molecules
AU763299B2 (en) * 1997-11-26 2003-07-17 Evolutec Limited Histamine and serotonin binding molecules

Also Published As

Publication number Publication date
HK1046362A1 (en) 2003-01-10
US20020151499A1 (en) 2002-10-17
MXPA02001807A (es) 2003-07-14
BR0013665A (pt) 2002-05-14
EP1207898B1 (de) 2005-02-16
PT1207898E (pt) 2005-05-31
DE60018192D1 (de) 2005-03-24
DE60018192T2 (de) 2005-12-29
AU780773B2 (en) 2005-04-14
WO2001015719A2 (en) 2001-03-08
NZ517218A (en) 2004-10-29
GB9920674D0 (en) 1999-11-03
DK1207898T3 (da) 2005-06-13
CA2382473A1 (en) 2001-03-08
US6737399B2 (en) 2004-05-18
WO2001015719A3 (en) 2001-05-10
CN1382057A (zh) 2002-11-27
EP1207898A2 (de) 2002-05-29
HK1046362B (zh) 2005-09-02
ES2235930T3 (es) 2005-07-16
AU6713900A (en) 2001-03-26
JP2003508445A (ja) 2003-03-04

Similar Documents

Publication Publication Date Title
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE60036968D1 (de) Adamantanderivate zur Behandlung von entzündlichen, immunologischen und kardiovaskulären Erkrankungen
DE69837295D1 (de) Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1
ATE260332T1 (de) Behandlung von textilien
NO20005888L (no) Benzimidazolderivater som mudulatorer av IgE
ATE301617T1 (de) Behandlung von wasser
ATE198895T1 (de) Verwendung von bindungsreagenzien gegen cd23 in der behandlung von autoimmunkrankheiten
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
TR200200673T2 (tr) Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması
DE69519577T2 (de) Prednisolonmetasulfobenzoat-zusammensetzung zur behandlung von entzündungserkrankung des darmes
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE60018192D1 (de) Behandlung von konjunktivitis mit histacalin proteinen
DE60103685D1 (de) Behandlung von Poriomania
DE60016762D1 (de) Behandlung von allergischer rhinitis mit bestimmten vasoaktiven aminbindenden proteinen
DE60122898D1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer-kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
DE60022125D1 (de) Tiefstkühlen von Waren
LU91009B1 (de) Behandlung von Verbrennungen
DE60017136D1 (de) Behandlung von angiogenese-abhängigen erkrankungen mit dextrinsulphat
DE60005154D1 (de) S-nitrosothiole als agentien zur behandlung von fehlfunktionen des kreislaufs
ATE331524T1 (de) Verwendung von lps zur behandlung intestinaler entzündungsprozesse
DE69908572D1 (de) Behandlung von metallen
DE29615626U1 (de) Salbe zur Behandlung von Neurodermitis und Akne
MA23887A1 (fr) Traitement des brulures avec une solution acide-base

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1207898

Country of ref document: EP

REN Ceased due to non-payment of the annual fee